RedShift BioAnalytics nets $18 mn

Burlington, Massachusetts-based RedShift BioAnalytics Inc, a provider of analytical instrumentation for the research, development and manufacture of protein therapeutic drugs, has raised $18 million in funding.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this